Cargando…

COVID-19 mortality effects of underlying health conditions in India: a modelling study

OBJECTIVE: To model how known COVID-19 comorbidities affect mortality rates and the age distribution of mortality in a large lower-middle-income country (India), and to identify which health conditions drive differences with high-income countries. DESIGN: Modelling study. SETTING: England and India....

Descripción completa

Detalles Bibliográficos
Autores principales: Novosad, Paul, Jain, Radhika, Campion, Alison, Asher, Sam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745455/
https://www.ncbi.nlm.nih.gov/pubmed/33328263
http://dx.doi.org/10.1136/bmjopen-2020-043165
_version_ 1783624610224275456
author Novosad, Paul
Jain, Radhika
Campion, Alison
Asher, Sam
author_facet Novosad, Paul
Jain, Radhika
Campion, Alison
Asher, Sam
author_sort Novosad, Paul
collection PubMed
description OBJECTIVE: To model how known COVID-19 comorbidities affect mortality rates and the age distribution of mortality in a large lower-middle-income country (India), and to identify which health conditions drive differences with high-income countries. DESIGN: Modelling study. SETTING: England and India. PARTICIPANTS: Individual data were obtained from the fourth round of the District Level Household Survey and Annual Health Survey in India, and aggregate data were obtained from the Health Survey for England and the Global Burden of Disease, Risk Factors and Injuries Studies. MAIN OUTCOME MEASURES: The primary outcome was the modelled age-specific mortality in each country due to each COVID-19 mortality risk factor (diabetes, hypertension, obesity and respiratory illness, among others). The change in overall mortality and in the share of deaths under age 60 from the combination of risk factors was estimated in each country. RESULTS: Relative to England, Indians have higher rates of diabetes (10.6% vs 8.5%) and chronic respiratory disease (4.8% vs 2.5%), and lower rates of obesity (4.4% vs 27.9%), chronic heart disease (4.4% vs 5.9%) and cancer (0.3% vs 2.8%). Population COVID-19 mortality in India, relative to England, is most increased by uncontrolled diabetes (+5.67%) and chronic respiratory disease (+1.88%), and most reduced by obesity (−5.47%), cancer (−3.65%) and chronic heart disease (−1.20%). Comorbidities were associated with a 6.26% lower risk of mortality in India compared with England. Demographics and population health explain a third of the difference in share of deaths under age 60 between the two countries. CONCLUSIONS: Known COVID-19 health risk factors are not expected to have a large effect on mortality or its age distribution in India relative to England. The high share of COVID-19 deaths from people under age 60 in low- and middle-income countries (LMICs) remains unexplained. Understanding the mortality risk associated with health conditions prevalent in LMICs, such as malnutrition and HIV/AIDS, is essential for understanding differential mortality.
format Online
Article
Text
id pubmed-7745455
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-77454552020-12-17 COVID-19 mortality effects of underlying health conditions in India: a modelling study Novosad, Paul Jain, Radhika Campion, Alison Asher, Sam BMJ Open Global Health OBJECTIVE: To model how known COVID-19 comorbidities affect mortality rates and the age distribution of mortality in a large lower-middle-income country (India), and to identify which health conditions drive differences with high-income countries. DESIGN: Modelling study. SETTING: England and India. PARTICIPANTS: Individual data were obtained from the fourth round of the District Level Household Survey and Annual Health Survey in India, and aggregate data were obtained from the Health Survey for England and the Global Burden of Disease, Risk Factors and Injuries Studies. MAIN OUTCOME MEASURES: The primary outcome was the modelled age-specific mortality in each country due to each COVID-19 mortality risk factor (diabetes, hypertension, obesity and respiratory illness, among others). The change in overall mortality and in the share of deaths under age 60 from the combination of risk factors was estimated in each country. RESULTS: Relative to England, Indians have higher rates of diabetes (10.6% vs 8.5%) and chronic respiratory disease (4.8% vs 2.5%), and lower rates of obesity (4.4% vs 27.9%), chronic heart disease (4.4% vs 5.9%) and cancer (0.3% vs 2.8%). Population COVID-19 mortality in India, relative to England, is most increased by uncontrolled diabetes (+5.67%) and chronic respiratory disease (+1.88%), and most reduced by obesity (−5.47%), cancer (−3.65%) and chronic heart disease (−1.20%). Comorbidities were associated with a 6.26% lower risk of mortality in India compared with England. Demographics and population health explain a third of the difference in share of deaths under age 60 between the two countries. CONCLUSIONS: Known COVID-19 health risk factors are not expected to have a large effect on mortality or its age distribution in India relative to England. The high share of COVID-19 deaths from people under age 60 in low- and middle-income countries (LMICs) remains unexplained. Understanding the mortality risk associated with health conditions prevalent in LMICs, such as malnutrition and HIV/AIDS, is essential for understanding differential mortality. BMJ Publishing Group 2020-12-16 /pmc/articles/PMC7745455/ /pubmed/33328263 http://dx.doi.org/10.1136/bmjopen-2020-043165 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Global Health
Novosad, Paul
Jain, Radhika
Campion, Alison
Asher, Sam
COVID-19 mortality effects of underlying health conditions in India: a modelling study
title COVID-19 mortality effects of underlying health conditions in India: a modelling study
title_full COVID-19 mortality effects of underlying health conditions in India: a modelling study
title_fullStr COVID-19 mortality effects of underlying health conditions in India: a modelling study
title_full_unstemmed COVID-19 mortality effects of underlying health conditions in India: a modelling study
title_short COVID-19 mortality effects of underlying health conditions in India: a modelling study
title_sort covid-19 mortality effects of underlying health conditions in india: a modelling study
topic Global Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745455/
https://www.ncbi.nlm.nih.gov/pubmed/33328263
http://dx.doi.org/10.1136/bmjopen-2020-043165
work_keys_str_mv AT novosadpaul covid19mortalityeffectsofunderlyinghealthconditionsinindiaamodellingstudy
AT jainradhika covid19mortalityeffectsofunderlyinghealthconditionsinindiaamodellingstudy
AT campionalison covid19mortalityeffectsofunderlyinghealthconditionsinindiaamodellingstudy
AT ashersam covid19mortalityeffectsofunderlyinghealthconditionsinindiaamodellingstudy